Finance Monthly CFO Awards 2019 Winners Edition

www.finance-monthly.com 69 Finance Monthly CFO Awards 2019 Senior Vice President & CFO of Fosun Pharma MS. GUAN XIAOHUI FIRM PROFILE Established in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is a leading healthcare group in the PRC. Adhering to the mission of improving human health, Fosun Pharma’s business covers all key sectors of healthcare industry chain, including pharmaceutical manufacturing andR&D, healthcare services, medical devices andmedical diagnosis, aswell as pharmaceutical distribution and retail, with pharmaceutical manufacturing and R&D as the core, and healthcare services as the development focus. Fosun Pharma regards innovation, research and development as the core driving factor of development and has developed international R&D team in China, the United States., India and etc., and established innovative chemical drugs platform, biologics platform, high-value generic drugs platform and cell-therapy platform. Currently, Fosun Pharma continues to focus on therapeutic areas including oncology, cardiovascular system, central nervous system, blood system, metabolism and alimentary system and anti-infection. All major products occupy the leading position and maintained fast growth in each market segment. In healthcare service segment, Fosun Pharma Group has strategically layout high-end medical in developed coastal cities, specialized and general hospital in second and third-tier cities. In 2018, the combined number of authorized beds controlled by Fosun Pharma including Chancheng Hospital, Hengsheng Hospital, Zhongwu Hospital, Wenzhou Geriatrics Hospital, Guangji Hospital, Jimin Cancer Hospital, Zhuhai Chancheng and Wuhan Jihe Hospital, etc. was 4,118 in aggregate. United family hospital, the affiliated hospital of Fosun Pharma Group, continues to maintain its leading position in premium healthcare in Beijing, Tianjin, Shanghai and other metropolitan in China. Looking forward, Fosun Pharma will adhere to the brand philosophy of “Innovation for Good Health”. Focusing on the unmet medical needs, it will stick to the development model of “organic growth, external expansion and integrated development” under the guidance of “4IN” strategy (Innovation, Internationalization, Integration, Intelligentization), striving to become a first-tier enterprise in the global mainstream pharmaceutical and healthcare market. www.fosunpharma.com ABOUT MS. GUAN XIAOHUI Ms. Guan Xiaohui is Senior Vice President and Chief Financial Officer of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Born in 1971, she has a Master’s Degree and is a Certified Public Accountant. Ms. Guan joined the Group in May 2000, successively holding the posts of Finance Manager of Medicine Circulation Business Division of the Company, Finance Controller of Shanghai Fosun Pharmaceutical Co., Ltd., Assistant Finance Controller of the Company, Deputy Director of Business Management Committee of the Company from January 2008 to May 2010, Assistant to the President and General Manager of Finance Department of the Company from May 2010 to June 2013, Chief Accountant and General Manager of Finance Department of the Company from June 2013 to December 2014, Vice President, Chief Accountant and General Manager of Finance Department of the Company from December 2014 to June 2015, and Senior Vice President and Chief Financial Officer of the Company since 18 June 2015. Before joining the Group, Ms. Guan worked for Bank of China Jiangxi Branch from July 1992 to May 2000. Finance Monthly CFO Awards 2019 CHINA